Comparative efficacy of ofatumumab oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons

Background: Evidence from network meta-analyses (NMAs) and real-world propensity score (PS) analyses suggest monoclonal antibodies (mAbs) offer a therapeutic advantage over currently available oral therapies and, therefore, warrant consideration as a distinct group of high-efficacy disease-modifying...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nicholas Riley, Christopher Drudge, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van der Walt, Erin O. Y. Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A. Samjoo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2024-03-01
coleção:	Therapeutic Advances in Neurological Disorders
Acesso em linha:	https://doi.org/10.1177/17562864241239453
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!